و هذه أفضل الأسهم التي وصى بها لعام 2004:
Below is a list we released on December 19th of our Top 10 Picks for 2004.
The "price when picked" was the price on December 19th.
On average our Top 10 Picks for 2004 were up 27.5% as of January 14th.
On average our Top 10 Picks for 2004 were up 47.1% as of March 5th.
1) APPI
Price When Picked: $0.025
Price on January 14th: $0.028 +12%
Price on March 5th: $0.019 -24%
I believe APPI is going to begin generating millions in revenues during the upcoming quarters from their cholesterol product Lo-Chol. Lo-Chol was proven in clinical studies to help lower total cholesterol up to 29%, triglycerides 45%, increase HDL, (good cholesterol) 60%, and improve the ratio of HDL to LDL 46%. Major distribution deals have already been signed and APPI has begun shipping orders. Infomercials will begin airing in the near-future advertising Lo-Chol with Ed McMahon as the spokesperson. I believe APPI only has upside from these levels and will at least see $0.10 next year.
2) ALTI
Price When Picked: $2.20
Price on January 14th: $3.37 +53%
Price on March 5th: $3.02 +37%
I believe ALTI is going to become one of the biggest nanotechnology plays next year. ALTI just received a $2 million grant with Western Michigan University and I believe will soon receive some of the $3.7 billion federal nanotechnology grant money that was approved this month by President Bush. ALTI is working on so many major projects right now including materials and technology for TiO2 pigment, TiO2 electrodes for titanium metal, pharmaceutical delivery structures (TiNano Spheres™), pharmaceuticals (RenaZorb™), dental materials and nanostructured materials for lithium ion batteries and fuel cells. I believe ALTI will easily become a $10 stock next year.
3) XDSL
Price When Picked: $0.39
Price on January 14th: $0.53 +36%
Price on March 5th: $0.50 +28%
XDSL has the technology to give telephone companies the ability to offer television services over copper telephone lines at the same time as traditional telephone services and high-speed Internet. While many people have televisions overseas, most of them do not have cable. Most people overseas that have televisions do have telephone lines which presents XDSL with a huge potential market. Revenues last quarter were up over 1,000% from just their DSL component business. Once they start seeing deployments of their television over DSL systems there is no telling how high revenues will go. I believe on news of a major contract XDSL will go above $1.
4) GNLK
Price When Picked: $0.60
Price on January 14th: $0.52 -13%
Price on March 5th: $0.43 -28%
GNLK allows cosmetic companies to offer skin cream that is customized to an individual's personal DNA. Because everybody's DNA is different, some skin creams work well on some people but not on others. I believe that there is a huge demand for customized DNA skin cream and that GNLK could potentially revolutionize the cosmetics industry. GNLK just recently announced a settlement with LAB21. We will soon find out how much money GNLK received and I expect GNLK to soon start reporting large increases in revenues. GNLK looks poised to break $1 in the near-future.
5) RDVN
Price When Picked: $0.29
Price on January 14th: $0.39 +34%
Price on March 5th: $0.26 -10%
RDVN during the past year has grown revenues on a quarterly basis from $2.074M to $3.448M to $4.071M to $5.092M. During the recent weeks RDVN has announced many large contracts including a contract to provide on-demand routine and non-routine maintenance on regional jet aircraft owned or operated by Mesa Airlines a $400 million NASDAQ company. I believe RDVN will continue to see large revenues increases during the upcoming quarters and that the stock is undervalued anywhere below $1.
6) EEGI (formerly EEGR)
Price When Picked: $1.11 (adjusted for 3 for 1 split)
Price on January 14th: $0.75 -33%
Price on March 5th: $3.75 +238%
EEGR already has an established 20 year old fabrication business with many well-known clients including Coke, Pepsi and Alcoa. Last quarter EEGR reported $810,000 in revenues just from the fabrication business alone. During the upcoming quarters we will begin to see revenues from EEGR's new 24/7 MRI business. The President of the MRI business played a major role in building Medical Resources, Inc. and U.S. Diagnostic Labs each into $400 million NASDAQ companies and now he plans to use a similar strategy to rapidly grow EEGR during the next year.
7) JMAR
Price When Picked: $1.70
Price on January 14th: $4.10 +141%
Price on March 5th: $2.75 +62%
JMAR is a nanotechnology company that develops lasers for semiconductor fabrication. JMAR is already doing over $18 million in revenues. With nanotechnology stocks becoming big plays I believe JMAR only has upside. Last time JMAR came into play back in 2000 it ran from the levels it is at now up to above $20 in a very short period of time. I believe JMAR will at least see $5 next year.
8) BLYC (formerly BTLY)
Price When Picked: $0.027
Price on January 14th: $0.037 +37%
Price on March 5th: $0.075 +178%
BLYC is a business-to-business Internet e-commerce company positioning itself to become a major player in the barter industry. The barter industry does over $12 billion in annual sales in the US alone. BLYC has developed their own VirtualBarter software which enables an Internet based worldwide network of barter and trade exchanges.
9) AKLM
Price When Picked: $0.61
Price on January 14th: $0.76 +25%
Price on March 5th: $0.63 +3%
AKLM is a developer and publisher of video game software. After doing $268 million in revenues and running to above $6 in 2002, the company ran into a financial crisis which brought it down to these levels. AKLM has done a good job of restructuring the company and lowering the net loss to only $4 million during the most recent quarter. If AKLM ever releases a hit game next year that sells well and allows the company to become profitable again, the stock should at least see $2-3.
10) DWVSF
Price When Picked: $0.12
Price on January 14th: $0.10 -17%
Price on March 5th: $0.105 -13%
DWVSF provides software and hardware solutions to the distribution and retail sectors of the economy for electronic merchandising of high value, high shrinkage prepaid products. With 44 million shares outstanding, DWVSF is valued at only $5.28 million. DWVSF has $2 million in cash, no debt, and a positive shareholder equity of $3.93 million. For two years now DWVSF has been profitable and showing major revenue growth. This stock is only waiting to become discovered.
و هذه توصياته ليوم 9 - 3 - 2004
March 9th, 2003:
We are profiling Arotech Corp. (ARTX) at $1.96 as a long-term strong buy.
ARTX provides defense and security products for the military, law enforcement and homeland security markets, including advanced zinc-air batteries, multimedia interactive simulators/trainers and lightweight armoring.
ARTX just had a huge quarter that was profitable on $5.7 million in revenues.
ARTX currently has a $17.6 million order backlog with revenues expected to double for 2004 over 2003.
ARTX has solid support at the $2 area and we look for it to move up above $3.
و سهم آخر ..
March 9th, 2003:
We are profiling Pharmanetics Inc. (PHAR) at $2.93 as a long-term strong buy.
PHAR through its wholly owned subsidiary, Cardiovascular Diagnostics, Inc. (CVDI), develops, manufactures and markets rapid diagnostics to dose, manage and screen patients on drugs affecting coagulation.
PHAR has bottomed out and is beginning to rebound. We believe that the worst is already factored into the stock and that things are due to get better.
PHAR has amazing technology for a company that is valued at less than $30 million.
PHAR is beginning to cut their workforce and reduce expenses which should help the company tremendously during the upcoming years.
.. الرجاء مراجعة الأسهم و رؤية مدى شرعيتها ..
.. الأسهم أعلاه موصاه من قبل الموقع الذي أشترك فيه و ليست توصيات مني لذى أرجو دراسة السهم قبل الإقدام على أي شيء ..
بمبلغ مو كبير بصراحه
